NASDAQ:HBIO

Harvard Bioscience, Inc Earning Date

USA |NASDAQ |USD

HBIO Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 3, 2021 Sep 2021 $0.06 $-0.01 $-0.03
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 3, 2021 Sep 2021 $27.91M $29.20M $24.04M

Harvard Bioscience, Inc's next earnings date is Wednesday, Nov 3, 2021 for the fiscal quarter ending Sep 2021.

HBIO Earnings Date & History Chart

HBIO Earnings & Revenue Forecast

HBIO Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 3 $0.11 $0.09 $0.13
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 3 $0.29 $0.27 $0.33
Dec 2022 3 $0.34 $0.32 $0.37

HBIO Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $0.11 $0.11 $0.12
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $0.29 $0.29 $0.31
Dec 2022 0 / 0 $0.34 $0.34 $0.40

HBIO Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 4 $32.85M $32.30M $34.00M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 4 $116.49M $114.40M $117.78M
Dec 2022 4 $126.49M $123.60M $129.55M

HBIO Earnings Date & Revenue History

HBIO Earnings History

|
Show More
Show More

HBIO Revenue History

|
Show More
Show More

Harvard Bioscience, Inc Next Earnings Date & Report

HBIO Next Earnings Date & Report Preview: Sep 2021 (FQ)

HBIO's next earnings date is Wednesday, Nov 3, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 3 analysts, the average EPS estimation for Harvard Bioscience, Inc's next quarterly earnings is $0.06, with a low EPS estimation of $0.06, and a high estimation of $0.06.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $0.06, the last 2 month trend is $0.06, and the 3 month trend is $0.06.

Based on 4 analysts, the average revenue estimation is $27.91M, with a low revenue estimation of $26.40M, and a high estimation of $29.04M.

Harvard Bioscience, Inc Previous Earnings Dates & Reports

HBIO Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Harvard Bioscience, Inc's previous earnings date was Aug 5, 2021 for its fiscal quarter ended Jun 30, 2021.

HBIO's earnings per share (EPS) was $-0.01, missing the consensus analysts forecast of $0.01 by -249.25%.

The EPS was higher than the previous fiscal quarter (Mar 2021) by -50.00%, and higher than the same period a year before (Jun 2020) by -75.00%.

Revenues were $29.20M, better than the forecast of $28.14M by 3.76%, up by 8.18% from the previous quarter , and up by 25.27% from the same period last year.

The company reported a net income of $-410.00K.

Free cash flow for the quarter was $562.00K , compared to $736.00K last quarter and $2.09M a year before.

HBIO ended the quarter with $52.17M in total debt, a decrease of -1.17% compared to the previous quarter, and an increase of 19.31% compared to the same quarter a year before.

HBIO Previous Earnings Date & Report Recap: Dec 2020 (FY)

Harvard Bioscience, Inc's previous annual earnings date was Mar 10, 2021 for its fiscal year ended Dec 31, 2020.

HBIO's earnings per share (EPS) was $-0.21, missing the consensus analysts forecast of $0.14 by -250.00% , and lower than the previous year's EPS (Dec 2019) by 61.54%.

Revenues were $102.10M, better than the forecast of $98.27M by 3.90%, and down by -12.12% from previous year's revenue.

The company reported a net income of $-7.81M.

Harvard Bioscience, Inc reported a free cash flow of $8.18M for its fiscal year, compared to $6.83M a year ago.

The company ended the fiscal year with $48.01M in total debt, a decrease of -10.80% compared to the previous year.